Endurant Capital Management’s Forte Biosciences FBRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,135	Closed	-$1.79M	–	55
2021 Q2	$1.79M	Buy	2,135 +1,031	+93%	+$866K	0.49%	50
2021 Q1	$946K	Buy	+1,104	New	+$946K	0.25%	55